author-photo

Tony Elliott

Manchester Academic Health Science Centre

95

Papers

3870

Citations

Citation Trend

Filter By

Papers (61) Sort By

Journal Conference Others

VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
SAPROCAN: Saracatinib (AZD0530) and docetaxel in metastatic,castrate-refractory prostate cancer (mCRPC)—A phase I/randomized phase II study by the United Kingdom National Cancer Research Institute Prostate Group.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
61MO Biomarker analysis of men with enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) + enza in KEYNOTE-199

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin: TOUCAN Phase II trial final

2020 BJUI
Show All
- Source
- Cite
- Save
Citations (0)
ProCAID: A randomized double-blind phase II clinical trial of capivasertib (C) in combination with docetaxel and prednisolone chemotherapy (DP) in metastatic castration-resistant prostate cancer (mCRPC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
623P KEYNOTE-199 phase II study of pembrolizumab plus enzalutamide for enzalutamide-resistant metastatic castration-resistant prostate cancer (mCRPC): Cohorts (C) 4 and 5 update

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin

2020 BJUI
Show All
- Source
- Cite
- Save
Citations (0)
227P Phase II study of pembrolizumab (pembro) plus enzalutamide for enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC): Cohorts (C) 4 and 5 update from KEYNOTE-199

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Learning the Ropes? On the Ropes? Making Sense of Headteacher Succession and Socialisation

2019
- Gerald Dunning
- Tony Elliott
Show All
- Source
- Cite
- Save
Citations (0)
A rare presentation of hidradenocarcinoma within the penis

2019 Urology case reports
Show All
- Source
- Cite
- Save
Citations (0)